Research Papers

25 of 325 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Highlights of the Fourth Canadian Symposium on Hepatitis C: Moving towards a National Action Plan.
Sagan SM; Dupont B; Grebely J; Krajden M; MacParland SA; Raven JF; Saeed S; Feld JJ; Tyrrell DL; Wilson JA.
Can J Gastroenterol Hepatol (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Validity, Reliability, and Responsiveness of the Brief Pain Inventory in Inflammatory Bowel Disease.
Jelsness-Jørgensen LP; Moum B; Grimstad T; Jahnsen J; Opheim R; Prytz Berset I; Hovde Ø; Torp R; Frigstad SO; Huppertz-Hauss G; Bernklev T.
Can J Gastroenterol Hepatol (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Red Blood Cell Transfusions and Iron Therapy for Patients Presenting with Acute Upper Gastrointestinal Bleeding: A Surv…
Fortinsky KJ; Martel M; Razik R; Spiegle G; Gallinger ZR; Grover SC; Pavenski K; Weizman AV; Kwapisz L; Mehta S; Gray S; Barkun AN.
Can J Gastroenterol Hepatol (Unknown)
Published: 2016
1/6 Transparent
Evaluation of Antiviral Therapy Performed after Curative Therapy in Patients with HBV-Related Hepatocellular Carcinoma:…
Yuan P; Chen P; Qian Y.
Can J Gastroenterol Hepatol (Unknown)
Published: 2016
1/6 Transparent
Computed Tomography Measurement of Hepatic Steatosis: Prevalence of Hepatic Steatosis in a Canadian Population.
Wells MM; Li Z; Addeman B; McKenzie CA; Mujoomdar A; Beaton M; Bird J.
Can J Gastroenterol Hepatol (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Adding Water to the Mill: Olmesartan-Induced Collagenous Sprue-A Case Report and Brief Literature Review.
Desruisseaux C; Bensoussan M; Désilets E; Tran HK; Arcand R; Poirier G; Wisniewski A; Manière T.
Can J Gastroenterol Hepatol (Unknown)
Published: 2016
1/6 Transparent
Interval Colorectal Cancers following Guaiac Fecal Occult Blood Testing in the Ontario ColonCancerCheck Program.
Paszat L; Sutradhar R; Tinmouth J; Baxter N; Rabeneck L.
Can J Gastroenterol Hepatol (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Assessment of a Colonoscopy Triage Sheet for Use in a Province-Wide Population-Based Colorectal Screening Program.
Sharara N; Nolan S; Sewitch M; Martel M; Dias M; Barkun AN.
Can J Gastroenterol Hepatol (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
The Palliative Management of Refractory Cirrhotic Ascites Using the PleurX (©) Catheter.
Reinglas J; Amjadi K; Petrcich B; Momoli F; Shaw-Stiffel T.
Can J Gastroenterol Hepatol (Unknown)
Published: 2016
1/6 Transparent
Hepatitis B Awareness and Knowledge in Asian Communities in British Columbia.
Yau AH; Ford JA; Kwan PW; Chan J; Choo Q; Lee TK; Kwong W; Huang A; Yoshida E.
Can J Gastroenterol Hepatol (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Unexpected Findings in Magnetic Resonance Enterography and Their Clinical Significance.
Ravindran S; Hancox SH; Barlow N; Dunk A; Howlett D.
Can J Gastroenterol Hepatol (Unknown)
Published: 2016
1/6 Transparent
Split-Dose Polyethylene Glycol Is Superior to Single Dose for Colonoscopy Preparation: Results of a Randomized Controll…
Mohamed R; Hilsden RJ; Dube C; Rostom A.
Can J Gastroenterol Hepatol (Unknown)
Published: 2016
2/6 Transparent
Registered
Domperidone Prescribing Practices Exposed Patients to Cardiac Risk despite a "Black Box" Warning: A Canadian Tertiary C…
Forbes N; Cooray M; Al-Dabbagh R; Yuan Y; Tse F; Liu LW; Xenodemetropoulos T.
Can J Gastroenterol Hepatol (Unknown)
Published: 2016
1/6 Transparent
Cloxacillin: A New Cause of Pill-Induced Esophagitis.
Zezos P; Harel Z; Saibil F.
Can J Gastroenterol Hepatol (Unknown)
Published: 2016
1/6 Transparent
Sofosbuvir-Based Therapy for Genotype 4 HCV Recurrence Post-Liver Transplant Treatment-Experienced Patients.
Ajlan A; Al-Jedai A; Elsiesy H; Alkortas D; Al-Hamoudi W; Alarieh R; Al-Sebayel M; Broering D; Aba Alkhail F.
Can J Gastroenterol Hepatol (Unknown)
Published: 2016
1/6 Transparent
Canadian Association of Gastroenterology Indicators of Safety Compromise following Colonoscopy in Clinical Practice.
Borgaonkar MR; Pace D; Lougheed M; Marcoux C; Evans B; Hickey N; O'Leary M; McGrath J.
Can J Gastroenterol Hepatol (Unknown)
Published: 2016
1/6 Transparent
Colonic Interposition between the Liver and Diaphragm: "The Chilaiditi Sign".
Nair N; Takieddine Z; Tariq H.
Can J Gastroenterol Hepatol (Unknown)
Published: 2016
1/6 Transparent
Age Is the Only Predictor of Poor Bowel Preparation in the Hospitalized Patient.
McNabb-Baltar J; Dorreen A; Al Dhahab H; Fein M; Xiong X; O' Byrne M; Ait I; Martel M; Barkun AN.
Can J Gastroenterol Hepatol (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Altered Esophageal Mucosal Structure in Patients with Celiac Disease.
Pinto-Sánchez MI; Nachman FD; Fuxman C; Iantorno G; Hwang HJ; Ditaranto A; Costa F; Longarini G; Wang XY; Huang X; Vázquez H; Moreno ML; Niveloni S; Bercik P; Smecuol E; Mazure R; Bilder C; Mauriño EC; Verdu EF; Bai JC.
Can J Gastroenterol Hepatol (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Colonic Stents for Colorectal Cancer Are Seldom Used and Mainly for Palliation of Obstruction: A Population-Based Study.
Borowiec AM; Wang CS; Yong E; Law C; Coburn N; Sutradhar R; Baxter N; Paszat L; Tinmouth J.
Can J Gastroenterol Hepatol (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Pure Oats as Part of the Canadian Gluten-Free Diet in Celiac Disease: The Need to Revisit the Issue.
de Souza MC; Deschênes ME; Laurencelle S; Godet P; Roy CC; Djilali-Saiah I.
Can J Gastroenterol Hepatol (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Validation of the Model of End-Stage Liver Disease for Liver Transplant Allocation in Alberta: Implications for Future …
Burak KW; Meeberg GA; Myers RP; Fick GH; Swain MG; Bain VG; Kneteman NM; Hilsden RJ.
Can J Gastroenterol Hepatol (Unknown)
Published: 2016
1/6 Transparent
Comment on "Yield of Screening Colonoscopy in Renal Transplant Candidates".
Therrien A; Bouin M.
Can J Gastroenterol Hepatol (Unknown)
Published: 2016
1/6 Transparent
Comment on "Hepatitis C and the Sex Trade".
Socías ME; Deering K; Montaner JS; Shannon K.
Can J Gastroenterol Hepatol (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Comment on "Biomarkers as Potential Treatment Targets in Inflammatory Bowel Disease: A Systematic Review".
Delicata NP; Azzopardi N; Ellul P.
Can J Gastroenterol Hepatol (Unknown)
Published: 2016
1/6 Transparent